<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Structure and dynamics of the ABL1 tyrosine kinase and its important role in chronic myeloid leukemia

Loading...
Thumbnail Image

Departments

School / College / Institute

Item type:Organizational Unit,

Program

Organization Authors

Co-Authors

Sever, Belgin

Tuyun, Amac Fatih

Otsuka, Masami

Fujita, Mikako

Ciftci, Halilibrahim

Date

Language

Type

Embargo Status

No

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Abelson (ABL1) tyrosine kinase is an essential component of non-receptor tyrosine kinases and is associated with numerous cellular processes, including differentiation and proliferation. The structural features of ABL1 include a distinct N-terminal cap region, a C-terminal tail, a bilobed kinase, SH2, and SH3 domains. These domains enable its engagement in several signaling cascades and dynamic control. The pathophysiology of chronic myeloid leukemia (CML) is mainly driven by the BCR-ABL1 oncoprotein, arising from dysregulation of ABL1 kinase, namely through its fusion to the breakpoint cluster region (BCR) gene. ABL1 is a crucial target in the treatment of CML as the BCR-ABL1 fusion causes uncontrolled cellular proliferation and resistance to apoptosis. Tyrosine kinase inhibitors (TKIs) targeting the ABL1 tyrosine kinase are playing a critical role in the treatment of CML through the inhibition of persistently activated signaling pathways mediated by the BCR-ABL1 fusion protein. The article examines the structural characteristics of ABL1, how they relate to CML, and the interactions between ABL1 and the current FDA-approved TKIs, emphasizing the kinase's critical function in carcinogenesis and its possible target status for tyrosine kinase inhibitors.

Source

Publisher

John Wiley and Sons Inc

Citation

item.page.haspartof

Source

Archiv der Pharmazie

item.page.ispartofseries

item.page.edition

DOI

10.1002/ardp.70005

item.page.datauri

item.page.link

Rights

CC BY-NC-ND (Attribution-NonCommercial-NoDerivs)

Copyrights Note

Creative Commons license

Except where otherwise noted, this item's license is described as CC BY-NC-ND (Attribution-NonCommercial-NoDerivs)

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators